The global label-free array systems market is fairly consolidated, with the top five vendors accounting for a major share of 62.7% in the market in 2015. Transparency Market Research (TMR) notes that these leading companies – Biacore, Agilent Technologies, ForteBio, Molecular Devices LLC, and Perkin Elmer – are constantly offering unparalleled product portfolios and making technology innovations to gain a competitive edge over others. Timely upgrades and continuous product launches are the key strategies adopted by the leading companies to consolidate their market shares in various regions.
According to TMR’s estimation, the global label-free array systems market was valued at US$1.0 bn in 2015 and is anticipated to attain a valuation of US$1.7 bn by 2024. The global market is forecast to expand at a CAGR of 5.6% from 2016 to 2024.
Robust R&D Spending in North America Lends Fillip to Market Growth
On the basis of geography, the global label-free array systems market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Of these, North America leads the global market. The regional market is estimated to occupy a major share in the coming years, and expected to register a CAGR of 5.7% during the forecast period. The regional market is primarily propelled by growing investments in research and development in the biotech and pharmaceutical sectors, accelerated adoptions of advanced technologies, and robust developments in drug discovery.
The primary end users of label-free array systems comprise research and development laboratories, contract research organizations (CROs), agriculture research institutes, and forensic institutes. Of these, research and development laboratories accounted for a major share in the global-label free array systems market in 2015. The increased spending on research and development by several biotechnology and pharmaceutical companies is a key trend that has fuelled the market growth. The demand for high-throughput equipment for discovering new molecules as promising drug candidates has boosted R&D spending in major regions, thus offering an impetus to the market.
Popularity of Outsourcing to Contract Research Organizations Creates Promising Market Avenues
The global label-free array systems market is expected to exhibit consistent growth fuelled by the demand for fast, accurate, and reliable results in molecular researches and in several drug discovery initiatives. Continuous advancement in technology has led to the design of high-throughput label-free array systems, which can offer real-time data analytics such as binding kinetics and affinity. In addition, the adoption of advanced label-free detection methods as plasmon sensing and nanowire sensing have enabled researchers the real-time monitoring of DNA amplification and finding novel biomarkers for cancer detection and treatment. Furthermore, unlike traditional labelled detection systems, the label-free array system ensures that the properties of the molecules under examination remain unaffected, thereby enhancing the accuracy of the results. All these factors are likely to open promising avenues in drug discovery and is expected to boost the market.
Recent developments point to the rapid outsourcing of a major chunk of R&D activities to contract research organizations. A large number of pharmaceutical companies are partnering with leading CROs to outsource researches on drug development, which help them reduce production cost and meet quality standards. This will boost the uptake on new technologies.
The study presented here is based on a report by Transparency Market Research (TMR) titled “Label-free Array Systems Market (Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS), and Quartz Crystal Microbalance; End Users - R&D Laboratories, Contract Research Organizations, Agriculture Research Institutes, and Forensic Institutes; Applications - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis, and Protein Complex and Cascade Analysis) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”
The global label-free array systems market is segmented on the basis of:
- Surface Plasmon Resonance (SPR)
- Bio-layer Interferometry (BLI)
- Cellular Dielectric Spectroscopy (CDS)
- Quartz Crystal Microbalance
- R&D Laboratories
- Contract Research Organizations
- Agriculture Research Institutes
- Forensic Institutes
- Drug Discovery
- Antibody Characterization & Development
- Protein Interface Analysis
- Protein Complex & Cascade Analysis
- North America
- Latin America
- The Middle East & Africa
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453